Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)

Katja Klausz, Sven Berger, Jeroen J. Lammerts van Bueren, Stefanie Derer, Stefan Lohse, Michael Dechant, Jan G.J. van de Winkel, Matthias Peipp, Paul W.H.I. Parren, Thomas Valerius*

*Corresponding author for this work
20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)'. Together they form a unique fingerprint.

Medicine & Life Sciences